Pralnacasan
Pralnacasan (VX-740) is a potent, selective, non-peptide and orally active interleukin-1β converting enzyme (ICE, caspase 1) inhibitor with a Ki of 1.4 nM. Pralnacasan inhibits proinflammatory cytokines IL-18, IL-1β , and IFN-γ. Pralnacasan has the potential for osteoarthritis and rheumatoid arthritis treatment[1][2].
Product Specifications
CAS Number
192755-52-5
Product Name Alternative
VX-740; HMR 3480
UNSPSC
12352005
Target
Caspase
Type
Reference compound
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pralnacasan.html
Purity
99.83
Solubility
DMSO : 220 mg/mL (ultrasonic)
Smiles
O=C([C@@H]1CCCN2N1C([C@@H](NC(C3=NC=CC4=C3C=CC=C4)=O)CCC2=O)=O)N[C@@H](C5)[C@H](OCC)OC5=O
Molecular Formula
C26H29N5O7
Molecular Weight
523.54
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
Caspase 1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![N-1-Naphthyl-N'-4-[2-sulfothioethyl]aminobutylurea](https://cdn.genprice.uk/products/572/4783839313073/imageurl/trc-n474970-25mg.webp)
N-1-Naphthyl-N'-4-[2-sulfothioethyl]aminobutylurea
